Skip to main content
. 2022 Mar;10(6):304. doi: 10.21037/atm-22-556

Figure 4.

Figure 4

DBH-AS1 increases the sensitivity of PC cells to gemcitabine. (A) qPCR analysis of DBH-AS1 levels in PC cells via following gemcitabine (0, 5, and 10 nM) treatment. (B) Representative growth curves for Canpan-2/gemcitabine and Canpan-2 cells. (C) qPCR analysis of DBH-AS1 levels in Canpan-2/gemcitabine and Canpan-2 cells. (D) qPCR analysis of DBH-AS1 levels in Canpan-2/gemcitabine following LV-NC or LV-DBH-AS1 treatment. (E) Representative growth curves for gemcitabine-treated Canpan-2/gemcitabine cells treated with LV-NC and LV-DBH-AS1, or Canpan-2 cells treated with shControl or shDBH-AS1. IC50, half-maximal inhibitory concentration. (A,C,D) t-test; (B,E) variance test. Data are means ± SEM from triplicate experiments, *, P<0.05. PC, pancreatic cancer; qPCR, quantitative polymerase chain reaction; sh, short hairpin.